{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:29:08Z","timestamp":1792013348504,"version":"4.4.0"},"reference-count":117,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,24]]},"DOI":"10.14218\/jcth.2020.00095","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T01:28:46Z","timestamp":1621819726000},"page":"000-000","source":"Crossref","is-referenced-by-count":15,"title":["A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis"],"prefix":"10.14218","volume":"000","author":[{"given":"Corey","family":"Saraceni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"4902","key":"key20210524012840_JCTH-D-20-00095-b3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"4902","key":"key20210524012840_JCTH-D-20-00095-b4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"key":"key20210524012840_JCTH-D-20-00095-b5","unstructured":"World Health Organization. Web Annex B. WHO estimates of the prevalence and incidence of hepatitis C virus infection by WHO region, 2015. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/277005\/WHO-CDS-HIV-18.46-eng.pdf"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1572-0241.2008.01825.x","article-title":"Acute hepatitis C: a systematic review","volume":"103","author":"Kamal","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"key20210524012840_JCTH-D-20-00095-b7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00535-007-2064-6","article-title":"The epidemiology of hepatitis C infection in the United States","volume":"42","author":"Rustgi","year":"2007","journal-title":"J Gastroenterol"},{"key":"key20210524012840_JCTH-D-20-00095-b8","first-page":"263","article-title":"Liver injury and disease pathogenesis in chronic hepatitis C. Curr Top Microbiol Immunol","volume":"369","author":"Yamane","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20210524012840_JCTH-D-20-00095-b9","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/cmi.2013.66","article-title":"HBV life cycle is restricted in mouse hepatocytes expressing human NTCP","volume":"11","author":"Li","year":"2014","journal-title":"Cell Mol Immunol"},{"issue":"16","key":"key20210524012840_JCTH-D-20-00095-b11","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1128\/JVI.79.16.10460-10466.2005","article-title":"Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus","volume":"79","author":"Jaoud\u00e9","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","article-title":"Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells","volume":"47","author":"Tuttleman","year":"1986","journal-title":"Cell"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0042-6822(90)90206-7","article-title":"In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway","volume":"175","author":"Wu","year":"1990","journal-title":"Virology"},{"issue":"17","key":"key20210524012840_JCTH-D-20-00095-b14","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00305-9","article-title":"Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection","volume":"16","author":"Baron","year":"2002","journal-title":"Immunity"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"key20210524012840_JCTH-D-20-00095-b17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"issue":"17","key":"key20210524012840_JCTH-D-20-00095-b18","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1128\/JVI.77.17.9511-9521.2003","article-title":"Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus","volume":"77","author":"Glebe","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0264-410X(89)90235-1","article-title":"Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective","volume":"7","author":"Neurath","year":"1989","journal-title":"Vaccine"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"issue":"7","key":"key20210524012840_JCTH-D-20-00095-b22","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","article-title":"Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 2008;134(7):1938-1949, 1949.e1-3","volume":"134","author":"Zhang","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"key":"key20210524012840_JCTH-D-20-00095-b24","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010;138(2):682-693, 693.e1-4","author":"Fisicaro"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b25","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"issue":"26","key":"key20210524012840_JCTH-D-20-00095-b26","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/vim.2011.0049","article-title":"Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B","volume":"25","author":"Nan","year":"2012","journal-title":"Viral Immunol"},{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.autrev.2016.09.006","article-title":"International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement","volume":"15","author":"Ferri","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hep.510290224","article-title":"Detection of occult low-grade b-cell non-Hodgkin\u2019s lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia","volume":"29","author":"Rasul","year":"1999","journal-title":"Hepatology"},{"issue":"9","key":"key20210524012840_JCTH-D-20-00095-b30","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhep.2013.08.020","article-title":"Reduction of HBV replication prolongs the early immunological response to IFN\u03b1 therapy","volume":"60","author":"Tan","year":"2014","journal-title":"J Hepatol"},{"issue":"8","key":"key20210524012840_JCTH-D-20-00095-b32","doi-asserted-by":"crossref","first-page":"e1005788","DOI":"10.1371\/journal.ppat.1005788","article-title":"Interferon alpha induces sustained changes in NK cell responsiveness to hepatitis B viral load suppression in vivo","volume":"12","author":"Gill","year":"2016","journal-title":"PLoS Pathog"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.21282","article-title":"Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B","volume":"44","author":"Wursthorn","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/jhep.2001.23045","article-title":"Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy","volume":"33","author":"Boni","year":"2001","journal-title":"Hepatology"},{"issue":"11","key":"key20210524012840_JCTH-D-20-00095-b36","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jama.1987.03400110056011","article-title":"Plasma-derived vs recombinant hepatitis B vaccine","volume":"258","author":"Gerety","year":"1987","journal-title":"JAMA"},{"issue":"24","key":"key20210524012840_JCTH-D-20-00095-b37","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4254\/wjh.v7.i24.2503","article-title":"Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine","volume":"7","author":"Walayat","year":"2015","journal-title":"World J Hepatol"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b38","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.20716","article-title":"Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness","volume":"41","author":"Godkin","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.173.3.531","article-title":"The cellular basis for lack of antibody response to hepatitis B vaccine in humans","volume":"173","author":"Egea","year":"1991","journal-title":"J Exp Med"},{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1046\/j.1440-1746.2001.02654.x","article-title":"Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees","volume":"16","author":"He","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0973-6247.33445","article-title":"Hepatitis B virus S gene escape mutants","volume":"1","author":"Purdy","year":"2007","journal-title":"Asian J Transfus Sci"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/172.4.934","article-title":"Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics","volume":"172","author":"Kohara","year":"1995","journal-title":"J Infect Dis"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"key20210524012840_JCTH-D-20-00095-b44","first-page":"87","article-title":"Hepatitis C virus entry","volume":"369","author":"Zeisel","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b46","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/gast.2001.27024","article-title":"Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response","volume":"121","author":"Kamal","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3748\/wjg.v8.i4.577","article-title":"Hepatitis C and HIV co-infection: a review","volume":"8","author":"Maier","year":"2002","journal-title":"World J Gastroenterol"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/gutjnl-2013-305707","article-title":"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial\u2014ANRS HB02 VAC-ADN","volume":"64","author":"Fontaine","year":"2015","journal-title":"Gut"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B","volume":"65","author":"Lok","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b50","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J Hepatol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhepr.2019.07.007","article-title":"Is PD-1 blockade a potential therapy for HBV?","volume":"1","author":"F\u00e9ray","year":"2019","journal-title":"JHEP Rep"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b52","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ajg.2014.11","article-title":"Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States","volume":"109","author":"Altekruse","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"1 Suppl","key":"key20210524012840_JCTH-D-20-00095-b53","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV virus taxonomy profile: Flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J Gen Virol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b55","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"Hepatitis C virus genotype 7, a new genotype originating from central Africa","volume":"53","author":"Murphy","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"22","key":"key20210524012840_JCTH-D-20-00095-b56","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.26097","article-title":"The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination","volume":"57","author":"Zahid","year":"2013","journal-title":"Hepatology"},{"issue":"27","key":"key20210524012840_JCTH-D-20-00095-b58","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry","volume":"285","author":"Harris","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat Med"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b60","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/v2051195","article-title":"Lipid metabolism and HCV infection","volume":"2","author":"Targett-Adams","year":"2010","journal-title":"Viruses"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4254\/wjh.v10.i2.186","article-title":"Hepatitis C virus: Morphogenesis, infection and therapy","volume":"10","author":"Morozov","year":"2018","journal-title":"World J Hepatol"},{"issue":"51","key":"key20210524012840_JCTH-D-20-00095-b62","doi-asserted-by":"crossref","first-page":"20509","DOI":"10.1073\/pnas.1105797108","article-title":"Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance","volume":"108","author":"Powdrill","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"key20210524012840_JCTH-D-20-00095-b63","doi-asserted-by":"crossref","first-page":"e1002881","DOI":"10.1371\/journal.ppat.1002881","article-title":"Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate","volume":"8","author":"Ribeiro","year":"2012","journal-title":"PLoS Pathog"},{"key":"key20210524012840_JCTH-D-20-00095-b64","author":"Choi","journal-title":"Viral molecular machines.New York, NY, USA:Springer Science.2012"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b65","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","article-title":"Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets","volume":"94","author":"Barba","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"key20210524012840_JCTH-D-20-00095-b66","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20210524012840_JCTH-D-20-00095-b67","first-page":"362","article-title":"Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles","volume":"2)","author":"Corless","journal-title":"J Gen Virol 2010;91(Pt"},{"issue":"1","key":"key20210524012840_JCTH-D-20-00095-b68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1089-3261(02)00068-5","article-title":"Immunopathogenesis of hepatitis C virus infection","volume":"7","author":"Chang","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciq156","article-title":"NK cells, innate immunity and hepatitis C infection after liver transplantation","volume":"52","author":"Nellore","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b70","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cells8040376","article-title":"Hepatitis C virus infection: Host-virus interaction and mechanisms of viral persistence","volume":"8","author":"Chigbu","year":"2019","journal-title":"Cells"},{"key":"key20210524012840_JCTH-D-20-00095-b71","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2016.06.009","article-title":"Innate immunity against hepatitis C virus","volume":"42","author":"Xu","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b72","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2893.2008.01014.x","article-title":"Natural killer cells suppress full cycle HCV infection of human hepatocytes","volume":"15","author":"Wang","year":"2008","journal-title":"J Viral Hepat"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b73","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2008.12.034","article-title":"Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model","volume":"136","author":"Jo","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b74","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","article-title":"Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C","volume":"117","author":"Gerlach","year":"1999","journal-title":"Gastroenterology"},{"issue":"8","key":"key20210524012840_JCTH-D-20-00095-b75","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/JVI.77.8.4781-4793.2003","article-title":"Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees","volume":"77","author":"Nascimbeni","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1574-6976.2011.00319.x","article-title":"Failure of innate and adaptive immune responses in controlling hepatitis C virus infection","volume":"36","author":"Thimme","year":"2012","journal-title":"FEMS Microbiol Rev"},{"issue":"8","key":"key20210524012840_JCTH-D-20-00095-b77","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b78","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/eji.200324539","article-title":"Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms","volume":"34","author":"Francavilla","year":"2004","journal-title":"Eur J Immunol"},{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b79","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1128\/JVI.78.12.6409-6419.2004","article-title":"Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt","volume":"78","author":"Yao","year":"2004","journal-title":"J Virol"},{"issue":"22","key":"key20210524012840_JCTH-D-20-00095-b80","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.01177-06","article-title":"PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion","volume":"80","author":"Urbani","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"key20210524012840_JCTH-D-20-00095-b81","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b82","doi-asserted-by":"crossref","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PLoS Pathog"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b83","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","article-title":"Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes","volume":"175","author":"Schulze zur Wiesch","year":"2005","journal-title":"J Immunol"},{"issue":"8981","key":"key20210524012840_JCTH-D-20-00095-b84","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"Diepolder","year":"1995","journal-title":"Lancet"},{"key":"key20210524012840_JCTH-D-20-00095-b85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0528.2002.017403.x","article-title":"Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection","volume":"174","author":"Eckels","year":"2000","journal-title":"Immunol Rev"},{"issue":"7","key":"key20210524012840_JCTH-D-20-00095-b86","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0198-8859(03)00070-3","article-title":"Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response","volume":"64","author":"Wang","year":"2003","journal-title":"Hum Immunol"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b87","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/intimm\/11.4.577","article-title":"Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus","volume":"11","author":"Eckels","year":"1999","journal-title":"Int Immunol"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b88","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/hep.20454","article-title":"An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection","volume":"40","author":"Cabrera","year":"2004","journal-title":"Hepatology"},{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b89","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Boettler","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"key20210524012840_JCTH-D-20-00095-b90","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2007.03.023","article-title":"Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection","volume":"47","author":"Ward","year":"2007","journal-title":"J Hepatol"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b91","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J Exp Med"},{"issue":"15","key":"key20210524012840_JCTH-D-20-00095-b92","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S1286-4579(99)00255-5","article-title":"TGF-beta1: immunosuppressant and viability factor for T lymphocytes","volume":"1","author":"Cerwenka","year":"1999","journal-title":"Microbes Infect"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b93","first-page":"1437","article-title":"Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection","volume":"38","author":"Sugimoto","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b94","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/cmi.2014.119","article-title":"Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients","volume":"12","author":"Zhai","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"key20210524012840_JCTH-D-20-00095-b95","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20050121","article-title":"Cellular immune selection with hepatitis C virus persistence in humans","volume":"201","author":"Cox","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b96","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.22242","article-title":"Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection","volume":"47","author":"Neumann-Haefelin","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b97","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1074-7613(01)00245-X","article-title":"The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes","volume":"15","author":"Erickson","year":"2001","journal-title":"Immunity"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b98","first-page":"376","article-title":"Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response","volume":"119","author":"Dazert","year":"2009","journal-title":"J Clin Invest"},{"issue":"23","key":"key20210524012840_JCTH-D-20-00095-b99","doi-asserted-by":"crossref","first-page":"11803","DOI":"10.1128\/JVI.00997-08","article-title":"Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs","volume":"82","author":"Salloum","year":"2008","journal-title":"J Virol"},{"issue":"12","key":"key20210524012840_JCTH-D-20-00095-b100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"200","author":"Timm","year":"2004","journal-title":"J Exp Med"},{"issue":"4","key":"key20210524012840_JCTH-D-20-00095-b101","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.24541","article-title":"Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations","volume":"54","author":"Neumann-Haefelin","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"key20210524012840_JCTH-D-20-00095-b102","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b103","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"issue":"5164","key":"key20210524012840_JCTH-D-20-00095-b104","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"issue":"13","key":"key20210524012840_JCTH-D-20-00095-b105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"issue":"9286","key":"key20210524012840_JCTH-D-20-00095-b106","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b107","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/gut.2004.057182","article-title":"Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response","volume":"54","author":"Kamal","year":"2005","journal-title":"Gut"},{"issue":"7062","key":"key20210524012840_JCTH-D-20-00095-b108","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"issue":"6","key":"key20210524012840_JCTH-D-20-00095-b109","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"10","key":"key20210524012840_JCTH-D-20-00095-b110","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.73.10.8469-8475.1999","article-title":"Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway","volume":"73","author":"Heim","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b111","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"Conjeevaram","year":"2006","journal-title":"Gastroenterology"},{"issue":"9","key":"key20210524012840_JCTH-D-20-00095-b112","doi-asserted-by":"crossref","first-page":"e2015756","DOI":"10.1001\/jamanetworkopen.2020.15756","article-title":"Cost-effectiveness of universal and targeted hepatitis C virus screening in the United States","volume":"3","author":"Tatar","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b113","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"issue":"22","key":"key20210524012840_JCTH-D-20-00095-b114","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourli\u00e8re","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"key20210524012840_JCTH-D-20-00095-b115","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2019.01.031","article-title":"Retreatment of patients who failed glecaprevir\/pibrentasvir treatment for hepatitis C virus infection","volume":"70","author":"Wyles","year":"2019","journal-title":"J Hepatol"},{"issue":"5 Suppl 1","key":"key20210524012840_JCTH-D-20-00095-b116","first-page":"S35","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"key20210524012840_JCTH-D-20-00095-b117","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.2001.1225","article-title":"Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins","volume":"292","author":"Shi","year":"2002","journal-title":"Virology"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2020-00095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:55Z","timestamp":1783707595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2020-00095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":117,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,5,24]]},"published-print":{"date-parts":[[2021,5,24]]}},"alternative-id":["10.14218\/JCTH.2020.00095"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2020.00095","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}